Open access peer-reviewed chapter

Postoperative Pain in Orthopedics

Written By

Lourdes Trinidad Castillo García, Fabiola Estela Elizabeth Ortega Ponce and Aurora Carolina Martínez Esparza

Submitted: 12 May 2023 Reviewed: 16 May 2023 Published: 23 June 2023

DOI: 10.5772/intechopen.111880

From the Edited Volume

Topics in Postoperative Pain

Edited by Victor M. Whizar-Lugo, Analucía Domínguez-Franco, Marissa Minutti-Palacios and Guillermo Dominguez-Cherit

Chapter metrics overview

128 Chapter Downloads

View Full Metrics

Abstract

Most patients who undergo orthopedic surgery experience moderate-to-severe discomfort. Historically, opioids have been the primary medication class used to treat pain transmission pathways. In orthopedic practice, multimodal analgesia has become the predominant method of pain management. Utilizing multiple medications to treat post-surgical pain reduces the need for narcotics and accelerates the healing process. By introducing effective analgesic treatments and interventions, this procedure reduces the use of perioperative opioids and, over time, the risk of opioid toxicity and addiction. Previous research has demonstrated that multimodal analgesia reduces the use of analgesics in the early postoperative period for orthopedic procedures. Numerous substances can stimulate or sensitize directly. When the peripheral nociceptors are damaged, direct damage to the nervous system results in pain. Preoperative, intraoperative, and postoperative symptoms are essential. The emphasis is on management regimes and the pathophysiology underlying the mechanism for postoperative discomfort. A concise description of the effects of painkillers is provided. containing information on specific conditions and average dosage substances are classified further. Both neuropathy and subjective pain should be treated. By focusing on multimodal analgesia, anesthesiologists can reduce pain more effectively. More advanced techniques are utilized for postoperative pain management after orthopedic surgery, thereby enhancing the patient’s short- and long-term outcomes.

Keywords

  • orthopedic surgery
  • multimodal analgesia
  • pain management
  • anesthesiology
  • regional anesthesia
  • opioids

1. Introduction

One of the most painful operations a patient can have is orthopedic surgery.

Pain is defined as “A unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage” by the new International Association for the Study of Pain (IASP) definition. Most patients who undergo orthopedic surgery, particularly total joint replacement, experience moderate to severe pain.

One of the most significant developments in the field of total joint replacement surgery has been the improvement of pain management. In these patients, effective pain management speeds up recovery, accelerates healing, and enhances quality of life after surgery. According to the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), pain has evolved into the “fifth vital sign” and must be taken into account when providing care for all patients. Throughout the entire inpatient and outpatient course, as well as when deciding whether to discharge a patient, pain must be taken into account. Pain must be treated, and failing to do so may result in medical malpractice claims. Since Professor Henrik Kehlet first proposed the idea of Enhanced Recovery After Surgery (ERAS), multimodal analgesia has gained popularity as a technique for treating pain. It requires for multidisciplinary cooperation between patients, doctors, anesthesiologists, physiotherapists, occupational therapists, and nursing staff and involves preoperative, perioperative, and postoperative components. When post-surgical pain is treated with multiple approaches, such as psychotherapy, physical therapy, regional anesthesia, local injections, and non-opioid medications, the recovery process is sped up, the need for opioids is reduced, and the risk of abuse is reduced. Multimodal analgesia has been proven in prior research to reduce both the length of stay and discomfort in the initial 24 hours following foot and ankle surgery. Opioid use was decreased postoperatively by combining periarticular injections with usual pain management for hip hemiarthroplasty. Injections at the surgical site for femur fracture and upper extremity surgeries reduced pain and raised overall patient satisfaction.

Advertisement

2. Incidence of pain

Postoperative pain is a common phenomenon after an orthopedic surgery and can be a limiting factor for the patient’s recovery. The incidence of postoperative pain can vary depending on the type and technique of the surgery.

It is well known that the joint replacement surgery and spine surgery are the most painful surgeries, postoperative talking. In a multicenter study, by Arefaine [1] et al., in 2020, they found that moderate to severe postoperative pain was present in 70.5% of patients who underwent an orthopedic emergency surgery. They also found that orthopedics patients who had preoperative anxiety were 6.42 times more likely to develop moderate to severe postoperative pain compared with those patients who were not anxious, among other factors like history of preoperative anxiety, history of preoperative pain, preoperative patient expectation about postoperative pain, intraoperative use of tourniquet, type of anesthesia and duration of anesthesia were significant.

To handle the postoperative pain in an orthopedic surgery, several strategies have been used. One of the most common strategies is opioid use. However, some of the adverse effects they can cause nausea, vomit, sedation, and constipation. Also, opioid use can be addictive and increase it overdose use. Another strategy for an adequate postoperative pain management is the use of peripheral nerve blocks; studies demonstrated higher reported patient satisfaction of postoperative pain control in patients who received combined [2].

Peripheral nerve blocks (PNB) have remarkable benefits for immediate postoperative pain control after primary total hip arthroplasty (THA). The analgesic effect of PNB with IV PCA was better than conventional IV PCA alone [3].

Multimodal Analgesia (MMA), also referred to as “balanced analgesia,” uses multiple analgesic medications, physical modalities, and cognitive strategies to affect peripheral and central nerve loci for the treatment of pain [4].

In regard of the technique, some studies found no significant difference in pain control, but they report significantly more effective in early mobilization with intraarticular infiltration [5].

2.1 Opioid overdose and addiction in the intrahospital setting

Opioid overdose and addiction are a common problem in the intrahospital setting, especially in patients who receive them for postoperative pain prolonged periods. Opioids are a class of analgesic that is highly effective and can be highly addictive and dangerous if wrongly used. According to a report from the CDC of the US, the rate of deaths for overdose use of opioids in the country went as high as 38% in 2019 and 2020, suggesting that the crisis is far from gone [6].

In the intrahospital setting, opioid overdose can occur as a result of an accidental or intentional overdose, or from an interaction with other medication. According to a study published in JAMA Surgery Magazine, 8.8% of patients that received opioids after a surgery developed addiction after 6 months [7]. In order to prevent overdose and addiction in the intrahospital setting, various strategies have been implemented. One of the most effective strategies is the protocol implementation for multimodal pain management, which imply the use of multiple analgesia modalities, like the peripheral nerve block and regional anesthesia [5]. They also implemented the use of short-action opioids and the reduction of prolonged-action opioids.

They have also implemented education and capacitation of medical and nurse professionals about the appropriate use of opioids and the early detection in its addiction, as well as the supervision of patients receiving opioids to detect early addiction or overdose signs. In conclusion, multimodal pain management protocol implementation, education and capacitation of medical and nurse professionals, and supervision are effective strategies for preventing these kinds of problems.

Advertisement

3. Postoperative pain in orthopedic surgery-associated factors

Postoperative pain is a common problem in orthopedic surgery and can have a meaningful impact on the patient’s quality of life. There are several factors associated with postoperative pain in orthopedic surgery, including its severity, patient’s age and anesthetic technique used. The severity of the surgery is an important factor that has been associated with postoperative pain, the more complex and invasive the surgery, for example, a total hip or knee arthroplasty, is associated with a higher incidence and severity of postoperative pain compared with simpler procedures like a fixed fracture [8]. Patient’s age has also been related with postoperative pain in orthopedic surgery. Older patients can have less pain tolerance and can require an adequate strategy for its management [9, 10]. The anesthetic technique used can also be a part of the postoperative pain. Peripheral nerve blocks and regional anesthesia have been associated with a reduction in postoperative pain and opioid use [11, 12].

In order to prevent and handle postoperative pain in orthopedic surgery, various strategies have been implemented. One of the most effective strategies is the protocol implementation for multimodal pain management, which imply the use of multiple analgesia modalities to reduce the use of opioids and help in the patient’s well-being [13]. They have also implemented patient’s education about pain management and early mobilization [14].

In conclusion, postoperative pain is a common problem in orthopedic surgery and is associated to several factors like severity of the surgery, patient’s age, and anesthetic technique used. Protocol implementation of multimodal pain management and patient’s education are effective strategies for the reduction of postoperative pain.

Advertisement

4. ERAS protocol in orthopedic surgery

The ERAS Protocol (Enhanced Recovery After Surgery), is a multidisciplinary approach designed for the patient’s recovery after surgery. This approach has been used widely in orthopedic surgery for the reduction in the intrahospital stay, postoperative pain, and opioid needs [15].

4.1 Components of enhanced recovery after surgery in orthopedic surgery

Preoperative interventions include patient’s education about the recuperation process, nutrition and hydration, as well as respiratory and cardiovascular optimization. Intraoperative interventions include use of regional and multimodal anesthesia to reduce the necessity of opioids. Postoperative interventions include early mobilization, multimodal pain management and early hospital discharge [16].

The principal postoperative undesirable sequelae include pain, cardiopulmonary, infectious and thromboembolic complications, cerebral dysfunction, gastrointestinal paralysis, nausea, and prolonged hospital stay. Surgical and anesthetic techniques are related to the presence or severity in which the adverse effects can be present. On the other hand, one must consider changes related to organic function, which are present in every patient that goes through a surgical procedure, commonly known as surgical stress.

It has been proven that ERAS Protocol effectively reduces the length in intrahospital stay, postoperative pain and opioid need. It has also been demonstrated that the ERAS Protocol positively affects cardiopulmonary function, quality of life and patient’s satisfaction [17]. However, implementation of the ERAS (Tables 1 and 2) Protocol in an orthopedic surgery can be quite challenging, as it requires an adequate collaboration between surgeons, anesthesiologists, nurses, and other healthcare specialists. Also, the ERAS Protocol implementation can require an expensive investment in resource and capacitation time.

Table 1.

ERAS in orthopedic surgery.

Table 2.

ERAS protocol implementation.

Advertisement

5. How does an inadequate treatment affect postoperative pain?

An inadequate treatment for postoperative pain can have a meaningful impact in a patient’s recovery and his experience in his whole hospital stay. Uncontrolled pain can lead to anxiety, depression and prolonged hospital stay.

Postoperative pain is a common complication after surgery and can be caused by tissue damage, inflammation, and nerve manipulation. If not adequately controlled, pain can lead to a series of complications, like a prolonged hospital stay, greater risk of infection, and respiratory complications [18]. Pain can also affect quality of life, which can lead to a negative impact in patient’s recuperation [19].

Advertisement

6. Pain’s pathways

Pain is a complex complication that involves multiple pathways and systems in the human body. Knowledge of the different pathways of pain is fundamental for the development of effective therapeutic strategies to control it in different clinical conditions.

Somatic pathway of pain activates by painful stimuli that affect somatic tissue, like skin muscle, bone, and joints. This pathway transmits over nervous myelinated A-Delta fibers and nervous non-myelinated C fibers. The information of this pathway is processed on the bone marrow and gets transmitted through the spinothalamic tract up to the thalamus and somatosensorial cortex of the brain [20].

Visceral pathway of pain activates by painful stimuli that affect internal organs, like the GI tract, heart, and lungs. This pathway transmits through the nervous non-myelinated C fibers. This pathway’s information processes in autonomous nervous ganglia and the bone marrow, and it transmits through spinothalamic tract and the spinoreticular tract up to the thalamus and somatosensorial cortex of the brain [21].

Neuropathic pathway of pain activates by lesions in the peripheral or central nervous system. This pathway transmits through nervous myelinated A-Delta fibers and nervous non-myelinated C fibers, The information in this pathway gets processed in the bone marrow and transmits through the spinothalamic tract and spinoreticular tract up to the thalamus and somatosensorial cortex of the brain. This pathway is particularly difficult to treat because of the chronic nature of the pain and the lack of response to conventional analgesic medication [22].

Advertisement

7. Analgesic scale

World Health Organization (WHO) analgesic scale is a tool used for the evaluation and treatment of pain. This scale is based on pain classification according to intensity and the selection of an adequate analgesic for the treatment. In this section, it will be discussed the importance of the WHO analgesic scale for the evaluation and pain treatment, along with different levels and recommendations for its use.

The WHO Analgesic Scale is divided into four levels, according to the intensity of pain and the type of analgesic recommended for its treatment. The first level corresponds to a mild pain, and the recommendation is to use non-opioid analgesic, like acetaminophen or Ibuprofen. The second level corresponds to a moderate pain, and the recommendation is to use weak opioids, like codeine or tramadol. The third level corresponds to an intense pain, and the recommendation is to use strong opioids, like morphine or fentanyl. The fourth level corresponds to a refractory pain, and the recommendation is to use additional treatment, such as local anesthesia or nerve blocks [23].

The WHO analgesic scale is an important and useful tool used for the evaluation and treatment of pain, because it gives us a clear guidance for the selection of the analgesic according to the intensity of pain. Also, this scale helps professional healthcare workers to evaluate the efficacy of treatment of pain and make dose adjustments according to the patient’s needs [24]. It is fundamental that this scale be used like a guidance and the treatment for pain must be individualized according to the needs of each patient. Professional healthcare workers must consider factors like age, comorbidities, individual sensibility and possible interaction with other medication [25].

Advertisement

8. Preventive analgesia

Focuses on postoperative pain control and the prevention of central sensitization and chronic neuropathic pain by providing analgesia administered preoperatively but not after surgical incision to reduce the intensity of postoperative pain [26]. Several studies have proven that preventive analgesia can aid postoperative analgesia and reduce the need of opioids after an orthopedic surgery. Preventive analgesia can also reduce inflammation and immune response, which can diminish the incidence of postoperative complications and shorten the patient’s treatment [27].

The options for treatment of preventive analgesia in orthopedic surgery include the preoperative administration of pain medication, like NSAIDs, corticosteroids, and lidocaine, the use of regional anesthesia like nerve blocks, intraoperative administration of analgesics like opioids and local anesthetics [28]. In spite of all the benefits that preventive analgesia can provide in an orthopedic surgery, there are some challenges associated with its implementation. Dose selection and the moment of the administration can be hard to determine and can vary according to the type of orthopedic surgery. Also, preventive analgesia can be expensive and require a more complex monitoring during the surgery [29].

Advertisement

9. Pain evaluation

Pain evaluation is an important part of the treatment during an orthopedic surgery. Acute postoperative pain can be difficult to control and can have fatal consequences if not treated in time. The pain scale is a simple tool commonly used to evaluate postoperative pain. It asks the patient to rate their pain on a scale of 0–10, where 0 represents the absence of pain and 10 represents the worst imaginable pain. The pain scale is easy to evaluate and has been validated for its use in postsurgical patients [30].

Another tool commonly used to evaluate the pain is the Visual Analog Scale (VSA), which consists of a horizontal line of 10 cm, with the words “No Pain” on one end and “Worst Possible Pain” on the other end. Patients mark over the line to show the level of pain they are experiencing. This scale has demonstrated its valid and easy reproduction for the evaluation of postoperative pain [31].

Besides the pain scales, patients can describe pain using descriptive terms, such as “oppressive,” “burn,” “throbbing,” or “colicky.” The use of these words can help doctors to determine the pain’s origin and choose the right treatment. In addition, the intensity of pain, a pain evaluation must include its location, duration, and effects on the physical function and quality of the patient’s life. A pain evaluation must include the psychological and social factors that can relate to the perception of pain and its response to the treatment [32].

It is important to take into consideration that the pain evaluation is subjective, and it can be affected by cultural, social, or emotional factors, and that is why it is important to consider the experience and perspective of the patient in order to determine the postoperative pain in an orthopedic surgery.

Advertisement

10. Regional anesthesia

The control of postoperative pain is a crucial issue because its effectiveness will or may hamper early rehabilitation [33]. Richman and coworkers performed a meta-analysis, which included 19 articles enrolling 603 patients, related to postoperative analgesia with continuous peripheral nerve blocks and opioids. All articles showed that perineural analgesia provided significantly better postoperative analgesia compared with opioids [34]. Regional anesthesia is the most appropriate way to control postoperative pain. However, improvement in pain control after single-shot administration is limited to the first 24 postoperative hours. Therefore, it is not likely to significantly change outcome because early rehabilitation during the first 2–3 postoperative days is necessary to minimize the accumulation of small amounts of periarticular blood and edema, the first stages of joint stiffness [35].

Regional anesthesia can be broadly divided into two categories: neuraxial anesthesia [spinal, epidural, combined spinal epidural (CSE)], and peripheral nerve blocks (upper and lower extremity blocks).

10.1 Neuraxial anesthesia

Spinal anesthetic is a great choice for lower limb orthopedic surgery. Delay in ambulation due to lower limb muscular weakness, the risk of urine retention of up to 17%, and pain following block regression are all factors that limit the use of spinal anesthetic in the ambulatory context. It is critical to choose the right agent for ambulatory spinal anesthesia [36].

The technique of inserting a needle or a catheter between the vertebrae and administering drugs into the epidural (epidural anesthesia) or subarachnoid space (spinal anesthesia) is known as neuraxial anesthesia (NA). The spinal nerve root is the target of NA. LA with adjuncts such as preservative-free opioids are the most common medications injected neuraxially. NA is frequently utilized in abdominal and lower extremity surgery. The length of surgical incision and surgical manipulation determine the sensory level required for a certain surgery. T10 is required for total hip arthroplasty (THA), open reduction and internal fixation of the femur, and hip fractures, whereas L1 is required for knee surgeries [37]. Spinal anesthesia is normally given as a single injection, whereas epidural anesthesia is given through an indwelling catheter for continuous infusion.

The level of spinal blockade is determined by the overall dose of LA combination, the baricity of the injected solution, and the patient’s position following the block. An epidural catheter allows for continuous drug infusion, extending the length of anesthesia. To avoid trauma to the termination of the conus medullaris, the spinal anesthetic needle is often inserted at the level of the L2–L3 interspace or below. The needle entry site for epidural anesthesia is determined by the extent of the dermatomes necessary for the treatment. It is frequently put in the mid to lower lumbar region for orthopedic surgeries. The volume of local anesthetic injected determines the degree of epidural blockade, whereas the concentration of the local anesthetic determines the density of the block. When compared to epidural anesthesia, spinal anesthesia results in a denser and more reliable block with a lower rate of block failure [38, 39].

10.2 Peripheral nerve blocks

PNB include injecting a LA solution to a single nerve or nerve bundle to create sensory and motor blocking of a specific body location. The LA prevents painful impulses from reaching the central nervous system. PNB can be used for anesthesia or analgesia after surgery. It is usually given as a single shot, although a continuous infusion catheter can be used to prolong the analgesic impact after surgery. PNB is usually performed under ultrasound guidance to limit the hazards of intraneural and intravascular LA injection, avoid peripheral nerve damage, and assure proper LA distribution for a successful block.

10.2.1 Blocks for upper extremity orthopedic procedures

Understanding upper extremity peripheral nerve blocking requires a thorough understanding of brachial plexus anatomy. The brachial plexus provides the majority of the upper extremity’s muscular and cutaneous nerve supply. The brachial plexus is made up of five ventral nerve roots (rami) that give rise to trunks, divisions, cords, and terminal branches. The nerve roots join together to produce the upper, middle, and lower trunks. The three trunks divide into six divisions, which join to produce three cords: lateral, posterior, and medial cords. The terminal branches of the three cords feed the majority of the upper extremity nerves. Nerves that are not part of the brachial plexus augment the cutaneous area of the shoulder and upper arm. The superficial cervical plexus (C3–C4) innervates the superior portion of the shoulder via the supraclavicular nerve. Seventy percent of the sensory innervation to the shoulder comes from the superior trunk via the suprascapular nerve, with the C5 and C6 nerve roots contributing the most. The second thoracic nerve root innervates the axilla. The brachial plexus is restricted at four points: The interscalene block is used to connect roots and trunks, the supraclavicular block is used to connect trunks and divisions, the infraclavicular block is used to connect cords, and the axillary block is used to connect terminal branches [40]. The most frequently performed upper limb blocks are shown in Table 3.

BlockClinical applicationNerves blockedAnatomical landmarksComplications
Interscalene nerve blockSurgeries involving the shoulder, proximal aspect of humerus, and the distal aspect of the clavicle(1) Brachial plexus: C5 to C7 and (2) cervical plexus: supraclavicular nerve (C3 and C4)LA injected between anterior and middle scalene muscles lateral to carotid artery and internal jugular vein(1) Phrenic nerve palsy (100%); (2) Horner syndrome; and (3) Hoarseness
Supraclavicular nerve blockSurgery of the arm, elbow, forearm, and hand. Extension into the interscalene area can cover shoulder proceduresC5–T1LA injected above the clavicle between anterior and middle scalene muscles at the level of the first rib, where the subclavian artery crosses over it(1) Pneumothorax; (2) phrenic nerve palsy; and (3) hoarseness
Infraclavicular nerve blockSurgery of the elbow, forearm and handC5–T1LA injected around the axillary artery below the clavicle, medial to coracoid processPneumothorax (relatively low incidence)
Axillary nerve blockSurgery of the elbow, forearm, and handMedian nerve, ulnar nerve, radial nerve, and musculocutaneous nerveLA injected around the axillary artery at the medial aspect of proximal arm(1) Hematoma formation; and (2) intravascular injection

Table 3.

Upper extremity blocks.

10.2.1.1 Interscalene block

The interscalene block is conducted at the brachial plexus roots-trunks level. The interscalene block anesthetizes C5–C8, as well as the supraclavicular branches of the cervical plexus C3–C4, which supply the skin over the acromion and the clavicle. The inferior trunk (C8–T1) is frequently spared; this is known as ulnar sparing. As a result, if this block is used for procedures at or near the elbow, an additional ulnar nerve block is required. This nerve block’s coverage makes it useful for treatments involving the shoulder, proximal aspect of the humerus, and distal aspect of the clavicle [41].

The brachial plexus is targeted by the interscalene block, which is located lateral to the carotid artery and internal jugular vein, directly above the collarbone. Complications of the interscalene block include near-complete phrenic nerve blockade, sympathetic chain blockade resulting in Horner’s syndrome, inadvertent injection in the vertebral artery, recurrent laryngeal nerve blockade resulting in hoarseness, and peripheral neuropathy. Pneumothorax, epidural injection, intrathecal injection resulting in total spinal anesthesia, spinal cord damage, and dorsal scapular or long thoracic nerve injury are also rare complications [42].

10.2.1.2 Supraclavicular block

The supraclavicular block targets the brachial plexus above the collarbone at the trunks and divisions. The C5–C7 distribution includes the more superficial and lateral branches that supply the shoulder, lateral aspect of the arm, and forearm, as well as the deeper and more medial dependent branches of C8 and T1 that supply the hand and medial aspect of the forearm. Adequate local anesthetic distribution in both locations is required for successful nerve block of the arm and hand. A local anesthetic is injected between the anterior and middle scalene muscles at the level of the first rib, where the subclavian artery passes posterior to the midpoint of the clavicle. Because all of the trunks and divisions of the brachial plexus are closely packed and may be anesthetized at this location, the supraclavicular block causes anesthesia of the upper limb, including the shoulder [41].

10.2.1.3 Infraclavicular block

The infraclavicular block impacts the brachial plexus at the level of the cords before the axillary and musculocutaneous nerves branch. It causes numbness in the upper limb below the shoulder, including the arm, elbow, forearm, and hand, while leaving the medial proximal upper arm, which is supplied by the intercostobrachial nerve (T2), unaffected [42].

The infraclavicular block is injecting local anesthetic around the axillary artery beneath the clavicle. Under ultrasound guidance, the local anesthetic is administered in a U-shaped pattern around the axillary artery, encompassing all three brachial plexus cords. The infraclavicular block has a low pneumothorax rate of 0.7% [43].

10.2.1.4 Axillary block

The axillary block is performed at the level of the brachial plexus branches. It anesthetizes the median nerve, the ulnar nerve, the radial nerve, and the musculocutaneous nerve, resulting in upper limb numbness from the mid-arm to the elbow, forearm, and hand. It should be noted that this block does not obstruct the axillary nerve; rather, the term of this regional treatment comes from the approach. The patient is positioned supine with the arm abducted to 90° in order to conduct this block. The median, ulnar, and radial nerves are identified as they surround the axillary artery using ultrasound guidance [44].

10.2.2 Lower extremity peripheral nerve blocks

Peripheral nerve blocks can be used as a primary anesthetic modality or as a supplement to general or neuraxial anesthesia. Lower extremity nerve blocks are commonly used as an adjuvant to general or neuraxial anesthesia due to anatomical restrictions in attaining appropriate surgical anesthesia by peripheral nerve blockade [45]. The most frequently performed lower limb blocks are shown in Table 4.

BlockClinical applicationNerves blockedAnatomical landmarksComplications
Femoral nerve (Femoral nerve block)Surgeries involving anterior aspect of the thigh and medial aspect of the leg below the kneeFemoral nerveInguinal crease; located lateral to femoral artery(1) LE weakness and falls; (2) bleeding; (3) infection; and (4) nerve damage
Femoral nerve (Fascia Iliaca block)Surgeries involving anterior aspect of the thigh and medial aspect of the leg below the knee(1) Femoral nerve and (2) lateral femoral cutaneous nerve of the thighInguinal crease, LA injected under fascia iliaca(1) LE weakness and falls; (2) bleeding; (3) infection; and (4) nerve damage
Sciatic nerve (Popliteal Block)Surgeries involving foot, ankle, posterior kneeSciatic nervePopliteal fossa, located cephalad to the knee near popliteal arteryMotor blockade
Saphenous nerve (Adductor Canal block)Surgeries involving medial aspect of knee, foot, and ankle(1) Saphenous nerve and (2) nerve to vastus medialis (branch of femoral nerve)Medial thigh, located deep to the sartorius muscle, adjacent to the femoral artery and vein(1) Bleeding; (2) infection; (3) nerve damage; and (4) potential lower extremity weakness at high doses
iPACKSurgeries involving the posterior knee capsuleArticular branches of the tibial, common peroneal, and obturator nerve to the posterior aspect of the kneePopliteal crease, located cephalad to femoral condylesInadvertent motor block due to local anesthetic spread to sciatic nerve branches

Table 4.

Lower extremity blocks.

10.2.2.1 Femoral nerve block

The femoral nerve block is used for lower extremity procedures that involve the anterior thigh and the medial side of the leg below the knee. The femoral nerve block is commonly used to provide analgesia for TKA, anterior cruciate ligament restoration, quadriceps tendon repair, foot surgery, and ankle surgery. The femoral nerve block can be coupled with other regional anesthetic methods, such as the sciatic nerve block, to broaden the anesthetic block’s distribution, especially below the knee [46].

The femoral nerve provides sensory innervation to the anterior thigh and medial aspects of the calf, foot, and ankle. The femoral nerve additionally provides motor innervation to muscles of the lower extremity, including the quadriceps, sartorius, and pectineus muscles. As such, the femoral nerve block will cause weakness of the quadriceps muscles [46, 47]. This may result in decreased patient mobility and may potentially increase the risk of falls. Thus, patients should not be ambulating without assistance after a femoral nerve block [47].

10.2.2.2 Iliac fascia block

The femoral nerve and lateral femoral cutaneous nerve are both anesthetized using the fascia iliac block, a regional anesthetic technique. It is used for analgesia following hip surgery or in people who have had catastrophic hip fractures. This block has been found to provide fast analgesic benefit and may be administered pre-operatively while the patient is waiting for their procedure. Additionally, patients reported gains from passive hip flexion, which enabled them to sit up in bed before surgery [48]. A shorter hospital stays, less discomfort, and a shorter time to fascia iliac block have all been linked to patients with hip fractures. When presented to the emergency room, a fascia iliac block can be performed, and research has shown that this block provides better pain relief than systemic intravenous opioid therapy. The fascia iliac block may also help these patients be positioned in the best way possible for the implantation of spinal anesthesia during surgical femur fracture repair [48, 49].

A rather significant volume of local anesthetic (20–30 cc) is injected under the fascia iliac, just above the level of the inguinal crease, to conduct the fascia iliac block. The purpose of this block, which is normally carried out under ultrasound guidance, is to disseminate local anesthetic medially to the femoral nerve and laterally to the iliac spine [50].

10.2.2.3 Adductor canal block

The adductor canal block effectively relieves pain during knee and medial lower limb surgery. For patients receiving TKA, it may be administered as a component of a multimodal analgesic pathway to promote early ambulation, enhance patient comfort, and boost patient satisfaction [51]. A majority of TKA patients will probably feel moderate-to-severe post-operative pain, which can lengthen recovery times, cause problems from immobility, and reduce patient satisfaction [52]. Therefore, for these patients, safe and efficient localized anesthetic procedures are crucial.

While the femoral nerve block can effectively reduce pain for patients having a complete knee replacement, it can also cause quadriceps muscle weakness, which may make a patient more likely to fall. Because of this, patients having TKR frequently find the adductor canal block to be a good choice for post-operative analgesia. The adductor canal block produces comparable levels of postoperative pain alleviation as the femoral nerve block while greatly sparing the quadriceps and preserving balance. This enables efficient pain management and the ability to encourage early mobilization and ambulation following surgery [53, 54]. The adductor canal block has widely become the standard of care for analgesia for total knee arthroplasty.

10.2.2.4 iPACK block

The iPACK block has been used more frequently in TKA to relieve pain without sacrificing the strength of the lower extremities in the posterior compartment of the knee. To effectively relieve pain in the posterior knee capsule, it targets the medial and lateral superior genicular nerves [55]. By guaranteeing coverage of both the anteromedial and posterior joints, the iPACK block and ACB together give a wider distribution of anesthetic coverage [55, 56].

According to recent research, the iPACK block, when combined with the adductor canal block and periarticular injection for TKA, significantly reduced postoperative pain during rest and ambulation [56, 57]. Early hospital discharge, a reduction in the need for opioids, and quicker ambulation were the outcomes.

Under ultrasound guidance, a needle is injected into the medial thigh to perform an iPACK block. This block typically uses a total volume of 15–20 cc of a local anesthetic solution. It is crucial to prevent accidental local anesthetic diffusion to the tibial or common peroneal nerve during the execution of this block, which could cause unfavorable motor weakness [58].

10.2.2.5 Sciatic nerve block

For lower extremity orthopedic procedures involving the foot, ankle, and posterior knee, a sciatic nerve block is indicated. The sciatic nerve block can be used alone, as in an Achilles tendon repair, or in conjunction with the femoral or saphenous nerve blocks to provide anesthetic coverage for knee surgery or foot/ankle surgery, respectively [59]. The sciatic nerve is the biggest nerve in the body, running from the anterior rami of L4 to S3. The tibial nerve and common peroneal nerve are the sciatic nerve’s terminal branches. With the exception of the medial lower leg and foot, which is supplied by the saphenous nerve, the sciatic nerve block delivers analgesia to the posterior portion of the knee, hamstrings, and the entire limb below the knee (motor and sensory innervation).

Depending on the region of the limb requiring anesthetic blockade, the sciatic nerve may be blocked in numerous locations. The sciatic nerve block is administered on the proximal medial thigh via the anterior route. The transgluteal approach is used on the back of the buttock, between the ischial tuberosity and the greater trochanter. The subgluteal approach is conducted on the gluteal crease from the back. The sciatic nerve block is commonly administered at the level of the popliteal fossa, sometimes known as the “popliteal block” [59].

10.2.2.6 Popliteal block

For foot and ankle surgery, the popliteal nerve block is used in conjunction with the saphenous nerve block. The popliteal fossa is where the sciatic nerve splits into two major terminal branches, the tibial nerve and the common peroneal nerve [45]. A popliteal block is commonly performed proximal to the bifurcation of the tibial and common peroneal nerves; however, a recent study suggests that a popliteal block performed distal to the sciatic nerve bifurcation may result in a 30% faster onset of blockade while still achieving terminal branch blockade [59]. Furthermore, injection of local anesthetic distal to the sciatic nerve bifurcation offers better sensory block of the lower extremity.

Nerve damage, hemorrhage, and intravascular injection are all possible consequences of a sciatic nerve block. Nerve damage can cause a chronic foot drop with possible pressure necrosis [45, 60].

11. Regional anesthesia in patients at risk of bleeding

There have been no prospective studies on peripheral nerve blocks in the presence of anticoagulants. The ASRA recommends the same guidelines for peripheral nerve blocks as for neuraxial procedures. Cases of psoas and retroperitoneal hematomas have been reported after lumbar plexus nerve blocks and psoas compartment nerve blocks. These patients were either on enoxaparin, ticlopidine, or clopidogrel. In some cases, the hematoma occurred in spite of adherence to the ASRA guidelines.

It is probably too restrictive to adapt the ASRA guidelines on neuraxial nerve blocks to patients undergoing peripheral nerve blocks. The European Society of Anesthesiology has noted that the guidelines for neuraxial nerve block do not routinely apply to peripheral nerve blocks. The Austrian Society of Anesthesiology, Resuscitation and Intensive Care, on the other hand, has suggested that superficial nerve blocks can be safely performed in the presence of anticoagulants. Because of the possibility of retroperitoneal hematoma, lumbar plexus and paravertebral nerve blocks merit the same recommendations as for neuraxial injections. The same guidelines should also apply to visceral sympathetic nerve blocks. The ASRA guidelines may, therefore, be applicable to nerve blocks in vascular and noncompressible areas, such as a celiac plexus nerve blocks, superior hypogastric plexus nerve blocks, and lumbar plexus nerve blocks [61].

12. Nonsteroidal anti-inflammatory drugs

The mechanism of NSAIDs (nonsteroidal anti-inflammatory drugs) not only has been described by the peripheral inhibition of prostaglandin synthesis but also through a variety of other peripheral and central mechanism. The central role that augments its known peripheral action, by which it promotes the production of endogenous opioid peptides [62].

The healing process of fractures is a complex process which includes a combination of sequential set of events that depends on the stability of the fracture. There are many factors that influence this process, including the use of NSAIDs. The use of NSAIDs has been studied for many years with debatable effects on bone healing. Humaid Al Farii et al conclude from his meta-analysis that NSAIDs that do not include indomethacin can be used for pain management without having a significant effect on bone healing and additionally, the use of NSAIDs for short duration, less tan2 weeks, does not show a statistical in nonunion [63].

NSAIDS are proven to be effective for musculoskeletal pain, with head-to-head clinical studies noting equivalent pain control with NSAIDs compared with opioids with a reduced risk profile. Contraindications with NSAIDs include peptic ulcer disease, chronic or end-stage renal disease, bronchial asthma, and breastfeeding women [64].

12.1 Acetaminophen

Like NDSAIDS acetaminophen may be used after surgery to reduce the amount of stronger, opioid medications you need to control pain. Acetaminophen does not interfere with the COX-1 or COX-2 enzyme to reduce pain, so does not have anti-inflammatory properties. Used alone, Works well for headaches, fever, and minor aches and pains, but does not reduce the inflammation and swelling that might accompany a muscle sprain.

13. Opioids

13.1 Tramadol

Tramadol is a synthetic, centrally acting analgesic agent with 2 distinct but complementary mechanisms of action: selectivity for μ receptor, although it binds weakly to the δ and κ receptors. The affinity for the μ receptor is ≈6000 fold less than morphine and 10-fold less than codeine. Inhibits reuptake of noradrenaline (norepinephrine) and 5-HT. Causes no clinically relevant respiratory depression in adults or children undergoing surgery and there are no clinically significant changes in oxygen saturation in adults and children receiving tramadol. In healthy adult volunteers and patients who underwent abdominal surgery, tramadol had no clinically relevant effects on gastrointestinal functioning [65].

Three studies evaluated the effects of tramadol on postoperative pain, opioid consumption, and complications after primary total joint arthroplasty (TJA). One high quality study compared the use of tramadol versus a placebo for treatment of pain after TJA. Another high-quality study compared tramadol to placebo and to paracetamol with codeine. One additional high-quality study compared tramadol to other opioid medications for treatment of pain after TJA. There were mixed results among all studies on the effects of tramadol on pain, patient-reported outcome scores, opioid consumption and adverse events after TJA. Adverse events including dizziness, dry mouth, and nausea were more common among patients who received tramadol compared to placebo. Given the conflicting evidence with regards to opioid consumption, the fact that two studies evaluated intravenous tramadol which is not approved by the Food and Drug Administration in the United States, and that there was inconclusive evidence comparing the efficacy of tramadol to other opioids the strength of the recommendation was downgraded to moderate [66, 67, 68].

13.2 Morphine

Immediate release opioids are preferred in the management of postoperative pain when simple analgesics are insufficient to achieve the analgesic goals. If modified-release opioid preparations (including transdermal) are used, due care should be exercised as they have been associated with harm. The prescribed dose of the immediate release opioids should be age related (rather than weight) and take into account renal function. Immediate-release oxycodone is not recommended as a first line opioid, because is more labor intensive to administer. However, it is recognized that in elderly patients over 70 years or in patients with renal failure, other opioids may be used post operatively [69].

13.3 Oxycodone

Oxycodone is a semisynthetic, μ-opioid receptor agonist with analgesic effects in several pain conditions. Acts also on κ-opioid receptors. Oxycodone and morphine are presumed to have a 1:1 ratio of analgesic potency in postoperative pain after surgery, with mixed somatic and visceral pain components. Oxycodone is metabolized by the cytochrome P450 enzyme system in the liver [70]. Shows the same adverse effects as those typically found for opioids, with constipation (25–30%), nausea (25–30%), and drowsiness (25%) being the three most common symptoms. Vomiting, pruritus, and dizziness occur in 5%–15% of patients taking oxycodone [71]. The potency ratio of oxycodone to fentanyl is less than 75:1. It is necessary to reduce the analgesic dose of oxycodone in elderly patients because metabolic clearance decreases with age.

Oxycodone for somatic pain such as pain after orthopedic surgery, the amount of oxycodone should be higher than the dose used for visceral pain. In a study of seventy-three patients undergoing orthopedic surgery randomly assigned to receive fentanyl or oxycodone using intravenous PCA, they concluded that with a 1:60 ratio of oxycodone to fentanyl in the application of PCA for pain control, the use of larger doses of oxycodone for 6 hours is effective in controlling early postoperative pain [72].

13.4 Transdermal buprenorphine

It is more described for chronic pain management, that persists for 12 weeks or more despite analgesia [73]. The role in the clinical management for acute pain is less clear, but it has been evaluated in the postoperative setting of hip fracture surgery, knee or hip arthroscopy/arthroplasty, shoulder surgery and spinal surgery. Is a partial agonist at the μ-opioid receptor [74, 75]. When the patch is applied prior to surgery and left in place for the prescribed seven days, it is associated with reduce postoperative pian, lower consumption of other analgesics, and patient satisfaction.

Is an opioid and a Schedule III controlled substance which means it is considered less dangerous tan Schedule II substances, such as morphine or oxycodone [76]. Buprenorphine has a ceiling effect for respiratory depression, meaning that the risk for opioid-induce respiratory depression does not increase beyond a certain dose. Has hepatic metabolization, it is safe for patients with renal dysfunction. This means buprenorphine can be administered to elderly patients and those with renal dysfunction without the need to adjust the dose [77].

The transdermal buprenorphine patch is available in 5, 10 and 20 μg/h doses and other doses can be achieved by cutting the patch or using two patches. The transdermal buprenorphine patch is to be discontinued after seven days with the plan of switching the patient to an oral opioid or some other pain reliever, it is recommended that the buprenorphine patch be removed and 24 hours elapse before the new medication is started. Based on recent clinical trials, buprenorphine is 75–100 times more potent than morphine [78].

14. Conclusion

Any general or regional anesthetic technique must always be tailored to the individual patient and the procedure, taking the potential benefits and risks into account. The contribution of the individual anesthesiologist in managing the RA or GA (regional anesthesia or general anesthesia) technique effectively and safely in order to obtain a positive outcome should not be undervalued. In spite of this, evidence suggests that RA confers additional benefits beyond the reduction of acute pain. These include a distinct reduction in pulmonary complications and a reduction in chronic pain after certain procedures. RA has also been associated with a reduction in cancer recurrence, blood transfusion, severe sepsis, intensive care unit admissions, and even a small reduction in mortality in some cases; however, these findings should be interpreted with greater caution. When CNB (central neuraxial blockade) is administered alone, as opposed to in conjunction with GA, the benefits are frequently greater. Logically, utilizing PNBs without GA and thereby avoiding CNB-mediated hypotension may offer the greatest benefit; however, the potential outcome advantages of PNBs are the area that has received the least amount of research.

Definitely postoperative pain can have a significative impact in the physiology of the body, including the activation of inflammatory mediators and changes in cardiovascular, respiratory and GI function. The understanding of these physiological alterations is of vital importance for the correct treatment of postoperative pain and possible postoperative complications.

Conflict of interest

The authors declare no conflict of interest.

Notes/thanks/other declarations

None.

References

  1. 1. Arefayne NR, Tegegne SS, Gebregzi AH, Mustofa SY. Incidence and associated factors of post-operative pain after emergency Orthopedic surgery: A multi-centered prospective observational cohort study. International Journal of Surgery Open. 2020;27:103-113. DOI: doi.org/10.1016/j.ijso.2020.10.003
  2. 2. Gianakos AL, Romanelli F, Rao N, Badri M, Lubberts B, et al. Combination lower extremity nerve blocks and their effect on postoperative pain and opioid consumption: A systematic review. The Journal of Foot and Ankle Surgery. 2021;60(1):121-131
  3. 3. Park HJ, Park KK, Park JY, Lee B, Choi YS, Kwon HM. Peripheral nerve block for pain management after total hip arthroplasty: A retrospective study with propensity score matching. Journal of Clinical Medicine. 2022;11(18):5456. DOI: 10.3390/jcm11185456 PMID: 36143103; PMCID: PMC9505421
  4. 4. Sampognaro G, Harrell R. Multimodal postoperative pain control after orthopaedic surgery. 2023. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. PMID: 34283438.
  5. 5. Karpetas GZ, Spyraki MK, Giakoumakis SI, Fligou FG, Megas PD, Voyagis GS, et al. Multimodal analgesia protocol for pain management after total knee arthroplasty: Comparison of three different regional analgesic techniques. Journal of Musculoskeletal & Neuronal Interactions. 2021;21(1):104-112 PMID: 33657760; PMCID: PMC8020020
  6. 6. Centers for Disease Control and Prevention. Drug overdose deaths. (2021). Available from: https://www.cdc.gov/drugoverdose/deaths/index.html
  7. 7. Brat GA, Agniel D, Beam A, Yorkgitis B, Bicket M, Homer M, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: Retrospective cohort study. BMJ. 17 Jan 2018;360:j5790. DOI: 10.1136/bmj.j5790. PMID: 29343479; PMCID: PMC5769574
  8. 8. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: A review. JAMA Surgery. 2017;152(3):292-298. DOI: 10.1001/jamasurg.2016.4952
  9. 9. Yang Y, Chen S, Li K, et al. Enhanced recovery after surgery (ERAS) in total hip arthroplasty: A systematic review and meta-analysis. The Journal of Arthroplasty. 2020;35(7):1965-1973.e6. DOI: 10.1016/j.arth.2020.02.068
  10. 10. Grant MC, Yang D, Wu CL, Makary MA, Wick EC. Impact of enhanced recovery after surgery and fast track surgery pathways on healthcare-associated in.
  11. 11. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged. Anesthesia and Analgesia. 2003;97:534-540
  12. 12. Wylde V, Rooker J, Halliday L, Blom AW. Acute postoperative pain at rest after hip and knee arthroplasty: Severity, sensory qualities and impact on sleep. Orthopaedics & Traumatology: Surgery & Research: OTSR. 2011;97:139-144
  13. 13. Memtsoudis SG, Poeran J, Cozowicz C, et al. The impact of regional anesthesia on long-term survival after total knee arthroplasty: A population-based cohort analysis. Anesthesiology. 2018;129:225-235
  14. 14. Joshi GP, Kehlet H. Multimodal analgesia techniques and postoperative rehabilitation. Anesthesiology Clinics. 2005;23(1):P185-P202. DOI: 10.1016/j.atc.2004.11.010
  15. 15. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. British Journal of Anaesthesia. 1997;78:606-617
  16. 16. Halawi MJ, Grant SA, Bolognesi MP. Multimodal analgesia for total joint arthroplasty. Orthopedics. 2015;38:e616
  17. 17. McLeod RS, Aarts MA, Chung F, Eskicioglu C, Forbes SS, Conn LG, et al. Development of an enhanced recovery after surgery guideline and implementation strategy based on the knowledge-to-action cycle. Annals of Surgery. Dec 2015;262(6):1016-1025. DOI: 10.1097/SLA.0000000000001067. PMID: 25692358
  18. 18. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: Risk factors and prevention. Lancet. 2006;367(9522):1618-1625. DOI: 10.1016/S0140-6736(06)68700-X
  19. 19. Clark C, Curry CS. Postoperative pain management: A survey of patients’ self-reported experiences. Journal of Pain Research. 2014;7:515-523. DOI: 10.2147/JPR.S63762
  20. 20. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267-284. DOI: 10.1016/j.cell.2009.09.028
  21. 21. Merskey H, Bogduk N. Classification of Chronic Pain. IASP Task Force on Taxonomy. 2nd ed. Seattle: IASP Press; 1994. Available from: http://www.iasp-pain.org/Education/content.aspx?ItemNumber=1698
  22. 22. Woolf CJ. Pain: Moving from symptom control toward mechanism-specific pharmacologic management. Annals of Internal Medicine. 2004;140(6):441-451. DOI: 10.7326/0003-4819-140-6-200403160-00010
  23. 23. World Health Organization. Cancer pain relief and palliative care. Technical Report Series, No. 804. Geneva: World Health Organization; 1990.
  24. 24. Carr DB, Jacox AK, Chapman CR, et al. Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical practice guideline No. 1. AHCPR publication No. 92-0032. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1992
  25. 25. Mercadante S. Principles of opioid therapy in cancer pain. Journal of Clinical Oncology. 2014;32(16):1662-1670. DOI: 10.1200/JCO.2013.50.7894
  26. 26. Vadivelu N, Mitra S, Schermer E, Kodumudi V, Kaye AD, Urman RD. Preventive analgesia for postoperative pain control: A broader concept. Local and Regional Anesthesia. 2014;29(7):17-22
  27. 27. Weibel S, Jokinen J, Pace NL, et al. Efficacy and safety of acetaminophen, ibuprofen, and naproxen sodium for pain relief after ambulatory surgery: A randomized clinical trial. Anesthesiology. 2019;131(2):281-293. DOI: 10
  28. 28. Lee IW, Schraag S. The use of intravenous lidocaine in perioperative medicine: Anaesthetic, analgesic and immune-modulatory aspects. Journal of Clinical Medicine. 2022;11(12):3543. DOI: 10.3390/jcm11123543 PMID: 35743617; PMCID: PMC9224677
  29. 29. Wang D, Liu Z, Zhou J, Yang J, Chen X, Chang C, et al. Barriers to implementation of enhanced recovery after surgery (ERAS) by a multidisciplinary team in China: A multicentre qualitative study. BMJ Open. 2022;12(3):e053687. DOI: 10.1136/bmjopen-2021-053687 PMID: 35288383; PMCID: PMC8921855
  30. 30. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Academic Emergency Medicine. 2001;8(12):1153-1157
  31. 31. Myles PS, Myles DB, Galagher W, Boyd D, Chew C, MacDonald N, et al. Measuring acute postoperative pain using the visual analog scale: The minimal clinically important difference and patient acceptable symptom state. British Journal of Anaesthesia. 2017;118(3):424-429. DOI: 10.1093/bja/aew466 PMID: 28186223
  32. 32. Sierżantowicz R, Lewko J, Bitiucka D, Lewko K, Misiak B, Ładny JR. Evaluation of pain management after surgery: An observational study. Medicina (Kaunas, Lithuania). 2020;56(2):65. DOI: 10.3390/medicina56020065 PMID: 32046199; PMCID: PMC7073849
  33. 33. Brown AR, Weiss R, Greenberg C, et al. Interscalene block for shoulder arthroscopy: Comparison with general anesthesia. Arthroscopy. 1993;9:295-300
  34. 34. Richman JM, Liu SS, Courpas G, et al. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesthesia and Analgesia. 2006;102:248-257
  35. 35. O’Driscoll SW, Giori NJ. Continuous passive motion (CPM): Theory and principles of clinical application. Journal of Rehabilitation Research and Development. 2000;37:179-188
  36. 36. Imarengiaye CO, Song D, Prabhu AJ, et al. Spinal anesthesia: Functional balance is impaired after clinical recovery. Anesthesiology. 2003;98:511-515
  37. 37. Carpenter RL, Caplan RA, Brown DL, Stephenson C, Wu R. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology. 1992;76:906-916 PMID: 1599111. DOI: 10.1097/00000542-199206000-00006
  38. 38. Memtsoudis SG, Sun X, Chiu YL, Stundner O, Liu SS, Banerjee S, et al. Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology. 2013;118:1046-1058 PMID: 23612126. DOI: 10.1097/ALN.0b013e318286061d
  39. 39. Pugely AJ, Martin CT, Gao Y, Mendoza-Lattes S, Callaghan JJ. Differences in short-term complications between spinal and general anesthesia for primary total knee arthroplasty. The Journal of Bone and Joint Surgery. American Volume. 2013;95:193-199 PMID: 23269359. DOI: 10.2106/JBJS.K.01682
  40. 40. Bruce BG, Green A, Blaine TA, Wesner LV. Brachial plexus blocks for upper extremity orthopaedic surgery. The Journal of the American Academy of Orthopaedic Surgeons. 2012;20:38-47 PMID: 22207517. DOI: 10.5435/JAAOS-20-01-038
  41. 41. Srikumaran U, Stein BE, Tan EW, Freehill MT, Wilckens JH. Upper-extremity peripheral nerve blocks in the perioperative pain management of orthopaedic patients: AAOS exhibit selection. The Journal of Bone and Joint Surgery. American Volume. 2013;95:e197 PMID: 24352782. DOI: 10.2106/JBJS.L.01745
  42. 42. Melton MS, Monroe HE, Qi W, Lewis SL, Nielsen KC, Klein SM. Effect of interscalene brachial plexus block on the pulmonary function of obese patients: A prospective, observational cohort study. Anesthesia and Analgesia. 2017;125:313-319 PMID: 28609340. DOI: 10.1213/ANE.0000000000002180
  43. 43. Desroches J. The infraclavicular brachial plexus block by the coracoid approach is clinically effective: An observational study of 150 patients. Canadian Journal of Anaesthesia. 2003;50:253-257 PMID: 12620948. DOI: 10.1007/BF03017794
  44. 44. Rodriguez J, Taboada M, Valino C, Barcena M, Alvarez J. A comparison of stimulation patterns in axillary block: Part 2. Regional Anesthesia and Pain Medicine. 2006;31:202Y205
  45. 45. Stein BE, Srikumaran U, Tan EW, Freehill MT, Wilckens JH. Lower-extremity peripheral nerve blocks in the perioperative pain management of orthopaedic patients: AAOS exhibit selection. The Journal of Bone and Joint Surgery. American Volume. 2012;94:e167 PMID: 23172334. DOI: 10.2106/JBJS.K.01706
  46. 46. Paul JE, Arya A, Hurlburt L, Cheng J, Thabane L, Tidy A, et al. Femoral nerve block improves analgesia outcomes after total knee arthroplasty: A meta-analysis of randomized controlled trials. Anesthesiology. 2010;113:1144-1162 PMID: 20966667. DOI: 10.1097/ALN.0b013e3181f4b18
  47. 47. Kwofie MK, Shastri UD, Gadsden JC, Sinha SK, Abrams JH, Xu D, et al. The effects of ultrasound-guided adductor canal block versus femoral nerve block on quadriceps strength and fall risk: A blinded, randomized trial of volunteers. Regional Anesthesia and Pain Medicine. 2013;38:321-325 PMID: 23788068. DOI: 10.1097/AAP.0b013e318295df80
  48. 48. Jones MR, Novitch MB, Hall OM, Bourgeois AP, Jeha GM, Kaye RJ, et al. Fascia iliaca block, history, technique, and efficacy in clinical practice. Best Practice & Research. Clinical Anaesthesiology. 2019;33:407-413 PMID: 31791559. DOI: 10.1016/j.bpa.2019.07.011
  49. 49. Candal-Couto JJ, McVie JL, Haslam N, Innes AR, Rushmer J. Pre-operative analgesia for patients with femoral neck fractures using a modified fascia iliaca block technique. Injury. 2005;36:505-510 PMID: 15755432. DOI: 10.1016/j.injury.2004.10.015
  50. 50. Yun MJ, Kim YH, Han MK, Kim JH, Hwang JW, Do SH. Analgesia before a spinal block for femoral neck fracture: Fascia iliaca compartment block. Acta Anaesthesiologica Scandinavica. 2009;53:1282-1287 PMID: 19650803. DOI: 10.1111/j.1399-6576.2009.02052.x
  51. 51. Kopp SL, Jacob AK, Hebl JR. Regional anesthesia in patients with preexisting neurologic disease. Regional Anesthesia and Pain Medicine. 2015;40:467-478 PMID: 26115188. DOI: 10.1097/AAP.0000000000000179
  52. 52. Li D, Alqwbani M, Wang Q , Liao R, Yang J, Kang P. Efficacy of adductor canal block combined with additional analgesic methods for postoperative analgesia in total knee arthroplasty: A prospective, double-blind, randomized controlled study. The Journal of Arthroplasty. 2020;35:3554-3562 PMID: 32680754. DOI: 10.1016/j.arth.2020.06.060
  53. 53. Soffin EM, YaDeau JT. Enhanced recovery after surgery for primary hip and knee arthroplasty: A review of the evidence. British Journal of Anaesthesia. 2016;117:iii62-iii72 PMID: 27940457. DOI: 10.1093/bja/aew362
  54. 54. Kuang MJ, Ma JX, Fu L, He WW, Zhao J, Ma XL. Is adductor canal block better than femoral nerve block in primary total knee arthroplasty? The Journal of Arthroplasty. 2017;32:3238-3248.e3 PMID: 28606458. DOI: 10.1016/j.arth.2017.05.015
  55. 55. Tran J, Giron Arango L, Peng P, Sinha SK, Agur A, Chan V. Evaluation of the iPACK block injectate spread: A cadaveric study. Regional Anesthesia and Pain Medicine. 2019;44:689-694. DOI: 10.1136/rapm-2018-100355. PMID: 31061110.02
  56. 56. Jinadu S, Pai P, Lai Y. Ambulatory knee replacements with IPACK block. Journal of Clinical Anesthesia. 2020;60:55-56 PMID: 31445181. DOI: 10.1016/j.jclinane.2019.08.021
  57. 57. Sankineani SR, Reddy ARC, Eachempati KK, Jangale A, Gurava Reddy AV. Comparison of adductor canal block and IPACK block (interspace between the popliteal artery and the capsule of the posterior knee) with adductor canal block alone after total knee arthroplasty: A prospective control trial on pain and knee function in immediate postoperative period. European Journal of Orthopaedic Surgery and Traumatology. 2018;28:1391-1395 PMID: 29721648. DOI: 10.1007/s00590-018-2218-7
  58. 58. Kim DH, Beathe JC, Lin Y, YaDeau JT, Maalouf DB, Goytizolo E, et al. Addition of infiltration between the popliteal artery and the capsule of the posterior knee and adductor canal block to periarticular injection enhances postoperative pain control in total knee arthroplasty: A randomized controlled trial. Anesthesia and Analgesia. 2019;129:526-535 PMID: 30234517. DOI: 10.1213/ANE.0000000000003794
  59. 59. Vloka JD, Hadzić A, April E, Thys DM. The division of the sciatic nerve in the popliteal fossa: Anatomical implications for popliteal nerve blockade. Anesthesia and Analgesia. 2001;92:215-217 PMID: 11133630. DOI: 10.1097/00000539-200101000-00041
  60. 60. Prasad A, Perlas A, Ramlogan R, Brull R, Chan V. Ultrasound-guided popliteal block distal to sciatic nerve bifurcation shortens onset time: A prospective randomized double-blind study. Regional Anesthesia and Pain Medicine. 2010;35:267-271 PMID: 20921838. DOI: 10.1097/AAP.0b013e3181df2527
  61. 61. Benzon HT, Jabri RS. Neuraxial anesthesia and peripheral nerve blocks in patietns on anticoagulants. In: Hadzic A, editor. NYSORA Textbook of Regional Anesthesia and Acute Pain Management. McGraw Hill; 2007. Available from: https://accessanesthesiology.mhmedical.com/content.aspx? bookid=413&sectionid=39828230
  62. 62. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52(Suppl 5):13-23
  63. 63. Al Farii H et al. The effect of NSAID son postfracture bone healing: A meta-analysis of randomized controlled trials. OTA International. 2021;4(2):e092
  64. 64. Sampognaro G, Harrell R. Multimodal postoperative pain control after orthopaedic surgery. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2021
  65. 65. Scott L, Perry C. Tramadol—A review of its use in perioperative pain. Drugs. 2000;60(1):139-176
  66. 66. Stiller C, Ludblad H, Weidnhielm L, Tullberg T, Grantinger B, Lafolie P, et al. The addition of tramadol to morphine via patient controlled analgesia does not lead to better postoperative pain relief after total knee artroplasty. Acta Anaesthesiologica Scandinavica. 2007;51:322-330
  67. 67. Stubhaug A, Grimstad J, Breivik H. Lack of analgesic effect of 50 and 100 mg oral tramadol after orthopaedic surgery: A randomized, doublé-blind, placebo and standard active drug comparison. Pain. 1995;62:11-18
  68. 68. Pang W-W, Mok MS, Lin C-H, Yang T-F, Huang M-H. Comparison of patient-controlled analgesia (PCA) with tramadol or morphine. Canadian Journal of Anesthesia. 1999;46:1030-1035
  69. 69. Srivastava D, Hill S, Carty S, Rockett M, Bastable R, Knaggs R, et al. Surgery and Opioids: Evidence-based expert consensus guidelines on the perioperative use of opioids in the United Kingdom. British Journal of Anaesthesia. Jun 2021;126(6):1208-1216. DOI: 10.1016/j.bja.2021.02.030. Epub 2021 Apr 14. PMID: 33865553
  70. 70. Sjövall S, Kokki M, Kokki H. Laparoscopic surgery: A narrative review of pharmacotherapy in pain management. Drugs. 2015;75:1867-1889
  71. 71. Ordoñez Gallego A, González Barón M, Espinosa AE. Oxycodone: A pharmacological and clinical review. Clinical & Translational Oncology. 2007;9:298-307
  72. 72. Don-won L, An J, Kim E, Lee J, Kim H. Comparison of oxycodone and fentanyl for postoperative patient-controlled analgesia after orthopedic surgery. Anesthesia and Pain Medicine. 2018;13:271-277
  73. 73. Pergolizzi J, Magnusson P. Transdermal buprenorphine for acute pain in the clinical setting: A narrative review. Journal of Pain Research. 2021;14:871-879
  74. 74. Desai SN, Badiger SV, Tokur SB, Naik PA. Safety and efficacy of transderal buprenorphine versus oral tramadol fo the treatment of post-operative pain following surgery for fracture neck of femur: A prospective, randomised clinical study. Indian Journal of Anaesthesia. 2017;61(3):225-229
  75. 75. Xu X, Xie L, Liu H, Hu Y. Transdermal buprenorphine patch versus oral celecoxib for pain management after total knee arthroplasty: An open-label, randomized controlled trial. Orthopaedics & Traumatology: Surgery & Research. 2020;106(5):915-919
  76. 76. Lopez MJ, Tadi P. Drug scheduling. Drug Enforcement Administration Drug Scheduling. [Updated 2022 Jun 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Jan 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557426
  77. 77. Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Practice. 2010;10(5):428-450
  78. 78. Sittl R, Likar R, Nautrup BP. Equipotent doses of transdermal fentanil and transdermal buprenorphine in patients with cancer and nocancer pain: Results of a retropective cohort study. Clinical Therapeutics. 2005;27(2):225-237

Written By

Lourdes Trinidad Castillo García, Fabiola Estela Elizabeth Ortega Ponce and Aurora Carolina Martínez Esparza

Submitted: 12 May 2023 Reviewed: 16 May 2023 Published: 23 June 2023